Cargando…
The TOP vector: a new high-titer lentiviral construct for delivery of sgRNAs and transgenes to primary T cells
Efficient delivery of nucleic acids for the engineering of primary T cells is central to the study of the basic biology of these key immune effector cells and has clinical implications. To date, lentiviral vectors delivering guide RNAs for CRISPR-Cas9 editing are not optimal for use in primary cells...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732963/ https://www.ncbi.nlm.nih.gov/pubmed/33335945 http://dx.doi.org/10.1016/j.omtm.2020.10.020 |
_version_ | 1783622187239866368 |
---|---|
author | Humes, Daryl Rainwater, Stephanie Overbaugh, Julie |
author_facet | Humes, Daryl Rainwater, Stephanie Overbaugh, Julie |
author_sort | Humes, Daryl |
collection | PubMed |
description | Efficient delivery of nucleic acids for the engineering of primary T cells is central to the study of the basic biology of these key immune effector cells and has clinical implications. To date, lentiviral vectors delivering guide RNAs for CRISPR-Cas9 editing are not optimal for use in primary cells. Herein, we describe the T cell optimized for packaging (TOP) vector for delivering guide RNAs and transgenes into primary T cells. The TOP vector produces high-titer virus compared to a routinely used guide RNA vector, resulting in a ~10-fold increase in transduction in T cells. Moreover, a TOP vector expressing a chimeric antigen receptor and a guide RNA targeting the T cell receptor showed an ~5- to 9-fold increased transduction efficiency with ~2- to 3-fold higher expression compared to the commonly used epHIV7 vector and was simultaneously able to mediate efficient knockout of the endogenous T cell receptor in >71% of transduced cells upon Cas9 electroporation. The increased packaging of the TOP vector genome into viral particles appears to contribute to its higher transduction efficiency. The TOP vector represents an optimal tool for tandem delivery of transgenes and guide RNAs to primary T cells for use in functional screens and immunotherapy applications. |
format | Online Article Text |
id | pubmed-7732963 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Society of Gene & Cell Therapy |
record_format | MEDLINE/PubMed |
spelling | pubmed-77329632020-12-16 The TOP vector: a new high-titer lentiviral construct for delivery of sgRNAs and transgenes to primary T cells Humes, Daryl Rainwater, Stephanie Overbaugh, Julie Mol Ther Methods Clin Dev Original Article Efficient delivery of nucleic acids for the engineering of primary T cells is central to the study of the basic biology of these key immune effector cells and has clinical implications. To date, lentiviral vectors delivering guide RNAs for CRISPR-Cas9 editing are not optimal for use in primary cells. Herein, we describe the T cell optimized for packaging (TOP) vector for delivering guide RNAs and transgenes into primary T cells. The TOP vector produces high-titer virus compared to a routinely used guide RNA vector, resulting in a ~10-fold increase in transduction in T cells. Moreover, a TOP vector expressing a chimeric antigen receptor and a guide RNA targeting the T cell receptor showed an ~5- to 9-fold increased transduction efficiency with ~2- to 3-fold higher expression compared to the commonly used epHIV7 vector and was simultaneously able to mediate efficient knockout of the endogenous T cell receptor in >71% of transduced cells upon Cas9 electroporation. The increased packaging of the TOP vector genome into viral particles appears to contribute to its higher transduction efficiency. The TOP vector represents an optimal tool for tandem delivery of transgenes and guide RNAs to primary T cells for use in functional screens and immunotherapy applications. American Society of Gene & Cell Therapy 2020-10-27 /pmc/articles/PMC7732963/ /pubmed/33335945 http://dx.doi.org/10.1016/j.omtm.2020.10.020 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Original Article Humes, Daryl Rainwater, Stephanie Overbaugh, Julie The TOP vector: a new high-titer lentiviral construct for delivery of sgRNAs and transgenes to primary T cells |
title | The TOP vector: a new high-titer lentiviral construct for delivery of sgRNAs and transgenes to primary T cells |
title_full | The TOP vector: a new high-titer lentiviral construct for delivery of sgRNAs and transgenes to primary T cells |
title_fullStr | The TOP vector: a new high-titer lentiviral construct for delivery of sgRNAs and transgenes to primary T cells |
title_full_unstemmed | The TOP vector: a new high-titer lentiviral construct for delivery of sgRNAs and transgenes to primary T cells |
title_short | The TOP vector: a new high-titer lentiviral construct for delivery of sgRNAs and transgenes to primary T cells |
title_sort | top vector: a new high-titer lentiviral construct for delivery of sgrnas and transgenes to primary t cells |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732963/ https://www.ncbi.nlm.nih.gov/pubmed/33335945 http://dx.doi.org/10.1016/j.omtm.2020.10.020 |
work_keys_str_mv | AT humesdaryl thetopvectoranewhightiterlentiviralconstructfordeliveryofsgrnasandtransgenestoprimarytcells AT rainwaterstephanie thetopvectoranewhightiterlentiviralconstructfordeliveryofsgrnasandtransgenestoprimarytcells AT overbaughjulie thetopvectoranewhightiterlentiviralconstructfordeliveryofsgrnasandtransgenestoprimarytcells AT humesdaryl topvectoranewhightiterlentiviralconstructfordeliveryofsgrnasandtransgenestoprimarytcells AT rainwaterstephanie topvectoranewhightiterlentiviralconstructfordeliveryofsgrnasandtransgenestoprimarytcells AT overbaughjulie topvectoranewhightiterlentiviralconstructfordeliveryofsgrnasandtransgenestoprimarytcells |